Correlation Between Champion Microelectronic and SynCore Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Champion Microelectronic and SynCore Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champion Microelectronic and SynCore Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champion Microelectronic Corp and SynCore Biotechnology Co, you can compare the effects of market volatilities on Champion Microelectronic and SynCore Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champion Microelectronic with a short position of SynCore Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champion Microelectronic and SynCore Biotechnology.

Diversification Opportunities for Champion Microelectronic and SynCore Biotechnology

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Champion and SynCore is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Champion Microelectronic Corp and SynCore Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SynCore Biotechnology and Champion Microelectronic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champion Microelectronic Corp are associated (or correlated) with SynCore Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SynCore Biotechnology has no effect on the direction of Champion Microelectronic i.e., Champion Microelectronic and SynCore Biotechnology go up and down completely randomly.

Pair Corralation between Champion Microelectronic and SynCore Biotechnology

Assuming the 90 days trading horizon Champion Microelectronic Corp is expected to generate 0.92 times more return on investment than SynCore Biotechnology. However, Champion Microelectronic Corp is 1.09 times less risky than SynCore Biotechnology. It trades about 0.14 of its potential returns per unit of risk. SynCore Biotechnology Co is currently generating about 0.08 per unit of risk. If you would invest  5,690  in Champion Microelectronic Corp on November 28, 2024 and sell it today you would earn a total of  180.00  from holding Champion Microelectronic Corp or generate 3.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Champion Microelectronic Corp  vs.  SynCore Biotechnology Co

 Performance 
       Timeline  
Champion Microelectronic 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Champion Microelectronic Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
SynCore Biotechnology 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in SynCore Biotechnology Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, SynCore Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Champion Microelectronic and SynCore Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Champion Microelectronic and SynCore Biotechnology

The main advantage of trading using opposite Champion Microelectronic and SynCore Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champion Microelectronic position performs unexpectedly, SynCore Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SynCore Biotechnology will offset losses from the drop in SynCore Biotechnology's long position.
The idea behind Champion Microelectronic Corp and SynCore Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities